These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1553942)

  • 1. Fulminant hepatic failure related to omeprazole.
    Jochem V; Kirkpatrick R; Greenson J; Brogan M; Sturgis T; Cook-Glenn C
    Am J Gastroenterol; 1992 Apr; 87(4):523-5. PubMed ID: 1553942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic anemia associated with the use of omeprazole.
    Marks DR; Joy JV; Bonheim NA
    Am J Gastroenterol; 1991 Feb; 86(2):217-8. PubMed ID: 1992636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic encephalopathy related to omeprazole].
    del Río Fernández M; Plagaro Cordero ME; de Frutos Arribas JF; Bellido Casado J; Velicia Llanes R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):574-5. PubMed ID: 9303628
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical utility and safety of omeprazole.
    Walan A
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].
    Castot A; Bidault I; Dahan R; Efthymiou ML
    Therapie; 1993; 48(5):469-74. PubMed ID: 8146827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole and the development of acute hepatitis.
    Koury SI; Stone CK; La Charité DD
    Eur J Emerg Med; 1998 Dec; 5(4):467-9. PubMed ID: 9919455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant hepatic failure associated with etodolac use.
    Mabee CL; Mabee SW; Baker PB; Kirkpatrick RB; Levine EJ
    Am J Gastroenterol; 1995 Apr; 90(4):659-61. PubMed ID: 7717333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole.
    Cheung G
    Conn Med; 1990 Jul; 54(7):392-3. PubMed ID: 2394098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
    Fimmel CJ; Blum AL
    Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Omeprazole. A new substance for inhibiting acid production].
    Uhl D
    Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.